Does BEVACIZUMAB-TNJN Cause Hepatic function abnormal? 5 Reports in FDA Database
Boost Your Natural Energy & Metabolism
Mitolyn — 6 exotic plants to unlock your body's fat-burning power. 90-day guarantee.
According to the FDA Adverse Event Reporting System (FAERS), 5 reports of Hepatic function abnormal have been filed in association with BEVACIZUMAB-TNJN (Avzivi tnjn). This represents 27.8% of all adverse event reports for BEVACIZUMAB-TNJN.
5
Reports of Hepatic function abnormal with BEVACIZUMAB-TNJN
27.8%
of all BEVACIZUMAB-TNJN reports
0
Deaths
5
Hospitalizations
How Dangerous Is Hepatic function abnormal From BEVACIZUMAB-TNJN?
Of the 5 reports, 5 (100.0%) required hospitalization, and 1 (20.0%) were considered life-threatening.
Is Hepatic function abnormal Listed in the Official Label?
This adverse event is not currently listed in the official FDA drug label for BEVACIZUMAB-TNJN. However, 5 reports have been filed with the FAERS database.
What Other Side Effects Does BEVACIZUMAB-TNJN Cause?
What Other Drugs Cause Hepatic function abnormal?
NIVOLUMAB (1,131)
PEMBROLIZUMAB (1,079)
METHOTREXATE (1,054)
CABOZANTINIB S-MALATE (912)
CYCLOPHOSPHAMIDE (824)
BEVACIZUMAB (769)
PACLITAXEL (603)
LENVATINIB (528)
ATORVASTATIN (520)
CYCLOSPORINE (508)